TEMODAR - 0085-1425-02 - (Temozolomide)

Alphabetical Index


Drug Information of TEMODAR

Product NDC: 0085-1425
Proprietary Name: TEMODAR
Non Proprietary Name: Temozolomide
Active Ingredient(s): 140    mg/1 & nbsp;   Temozolomide
Administration Route(s): ORAL
Dosage Form(s): CAPSULE
Coding System: National Drug Codes(NDC)

Labeler Information of TEMODAR

Product NDC: 0085-1425
Labeler Name: Merck Sharp & Dohme Corp.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA021029
Marketing Category: NDA
Start Marketing Date: 19990811

Package Information of TEMODAR

Package NDC: 0085-1425-02
Package Description: 1 BOTTLE, GLASS in 1 CARTON (0085-1425-02) > 14 CAPSULE in 1 BOTTLE, GLASS

NDC Information of TEMODAR

NDC Code 0085-1425-02
Proprietary Name TEMODAR
Package Description 1 BOTTLE, GLASS in 1 CARTON (0085-1425-02) > 14 CAPSULE in 1 BOTTLE, GLASS
Product NDC 0085-1425
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Temozolomide
Dosage Form Name CAPSULE
Route Name ORAL
Start Marketing Date 19990811
Marketing Category Name NDA
Labeler Name Merck Sharp & Dohme Corp.
Substance Name TEMOZOLOMIDE
Strength Number 140
Strength Unit mg/1
Pharmaceutical Classes Alkylating Activity [MoA],Alkylating Drug [EPC]

Complete Information of TEMODAR


General Information